The skin test with tuberculous recombinant allergen AT successful treated patients with lung tuberculosis


Cite item

Full Text

Abstract

38 patients with newly diagnosed tuberculosis, immediately after the end of the main course of treatment, when they were transferred to the third group of dispensary supervision (6-9 months) and when they were removed from the dispensary supervision (2-3 years later), a skin test with an allergen tuberculous recombinant was made. The positive skin test with tuberculosis recombinant allergen was defined at 20 patients - 13 mm. At the moment of removing to the III group only one skin test with tuberculosis allergen recombinant became negative, 19 (94,5%) patients had positive reactions - 13±2,3 mm. At the time of discharging from dispensary the positive reactions were determined at 16 (80%) cases - 10±2,3 mm, p<0,05. In this group, 13 (65%) patients had normergic skin tests with tuberculosis allergen recombinant and 7 (35%) - hyperergic tests. At the time of removing to the III group at five from seven patients with hyperergic tests the results remained the same, median and at the moment of discharging from tuberculosis service only one patient had the hyperergic skin test with tuberculosis allergen recombinant - 18mm. Among patients with normergic skin tests with tuberculosis allergen recombinant at the time of group III removing median was 11±2,1 mm. At the last dynamic control the normergic results were determined at 15 (75%) patients and the tests median remained almost unchanged - 10±1,8 mm, the differences are reliable compared to the initial data (p<0,05). In group which included 18 patients with negative skin tests with tuberculous allergen recombinant, the skin response stayed negative throughout all examination period except for one patient so patients of this group had not only clinical, radiological and bacteriological, but immunological signs of involution of the tuberculosis process. The study of the influence of clinical, epidemic and social factors to skin reaction showed that first group patients were significantly more likely to be unemployed (30% versus 5,5%; p<0,05) whereas in second group married patients were reliably registered (61,1% versus 25%; p<0,05). Other factors differed unreliably.

About the authors

G S Balasanyants

Военно-медицинская академия им. С.М. Кирова

Email: vmeda-nio@mil.ru

N V Skotnikova

Противотуберкулезный диспансер № 5

V V Dantsev

Военно-медицинская академия им. С.М. Кирова

Email: vmeda-nio@mil.ru

References

  1. Аксенова, В.А. Эффективность различных скрининговых мето- дов раннего выявления туберкулеза у детей и подростков / В.А. Аксенова [и др.] // Вопр. практ. педиатрии. - 2016. - Т. 11, № 4. - С. 9-17.
  2. Бармина, Н.А. Скрининговое обследование детей и под- ростков III, IV и V групп здоровья с применением нового диагностического теста / Н.А. Бармина [и др.] // Туберкулез и болезни легких. - 2015. - № 5. - С. 40-41.
  3. Долженко, Е.Н. Диагностические возможности аллергена туберкулезного рекомбинантного в скрининг-диагностике туберкулезной инфекции у детей подросткового возраста в Рязанской области / Е.Н. Долженко [и др.] // Туберкулез и болезни легких. - 2015. - № 6. - С. 31-36.
  4. Клинические рекомендации: латентная туберкулезная инфек- ция (ЛТИ) у детей. - 2016. - 44 с.
  5. Литвинов, В.И. Латентная туберкулезная инфекция - миф или реальность / В.И. Литвинов // Туберкулез и болезни легких. - 2011. - № 6. - С. 3-9.
  6. Парфенова, Т.А. Опыт использования в противотуберкулезных учреждениях аллергена туберкулезного рекомбинантного для диагностики туберкулезной инфекции / Т.А. Парфенова // Туберкулёз и болезни лёгких. - 2016. - Т. 94, № 9. - С. 49-52. ВЕСТНИК РОССИЙСКОЙ ВОЕННО-МЕДИЦИНСКОЙ АКАДЕМИИ 3 (63) - 2018 19 Клинические исследования
  7. Приказ МЗ РФ № 109 от 21.03.2003 «О совершенствовании противотуберкулезных мероприятий в Российской Фе- дерации», приложение № 7 «Инструкция по организации диспансерного наблюдения и учета контингентов противо- туберкулезных учреждений». - М., 2003. - С. 47-53.
  8. Приказ Минздрава России от 29.12.2014 № 951 «Об утверж- дении методических рекомендаций по совершенствованию диагностики и лечения туберкулеза органов дыхания». - М., 2014. - 39 с.
  9. Слогоцкая, Л.В. Динамика кожной пробы (диаскинтест) у де- тей при оценке активности туберкулезной инфекции/ Л.В. Слогоцкая [и др.] // Туберкулез и болезни легких. - 2011. - № 2. - С. 59-63.
  10. Ling, D. Immune-based diagnostics for TB in children: what is the evidence?/ D. Ling [et al.] // Paediatr. Respir. Rev. - 2011. -Vol. 12, № 1. - Р. 9-15.
  11. Mack, U. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement / U. Mack [et al.] // Eur. Respir. J. - 2009. - Vol. 33. - P. 956-973.
  12. Menzies, T. Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research march // T. Menzies [et al.] // Annals. Intern. Med. - 2007. - Vol. 146. - P. 340-354.
  13. Mori, T. Specific detection of tuberculosis infection: an interferon- y-based assay using new antigens / T. Mori [et al.] //Am. J. Respir. Crit. Care. Med. - 2004. - Vol. 170. - Р. 59-64
  14. Munk, M. Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis / M. Munk [et al.] // J. Infect. Dis. - 2001. - Vol. 183, № 1. - Р. 175-176.
  15. Vordermeier, H. Correlation of ESAT-6- specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis / H. Vordermeier [et al.] // Infect. Immun. - 2002. -Vol. 70. - Р. 3026-3032.
  16. World Health Organization (2011) Use of tuberculosis interferon- gamma release assays (IGRAs) in low- and middle-income countries. Policy Statement. - 2011. - P. 1-61.
  17. Yunfeng, D. Tuberculosis prevention in healthcare workers in China 10 years after the severe acute respiratory syndrome pandemic / D. Yunfeng [et al.] // ERJ Open Res. - 2015. - № 1. - P. 15-18.

Copyright (c) 2018 Balasanyants G.S., Skotnikova N.V., Dantsev V.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies